• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Burning Rock Biotech Ltd ADR (NQ: BNR )

    2.988 -0.022 (-0.73%)
    Streaming Delayed Price Updated: 9:34 AM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Burning Rock Biotech Ltd ADR

    < Previous 1 2 Next >
    NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces Changes to Management and Board of Directors
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Reports Second Quarter 2024 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Reports First Quarter 2024 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Publishes 2023 Annual Report on Form 20-F
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces ADS Ratio Change
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces Receipt of Notification from NASDAQ
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces Results of 2023 Annual General Meeting
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Reports Third Quarter 2023 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Reports Second Quarter 2023 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces Resignation and Appointment of Directors
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Reports First Quarter 2023 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Publishes 2022 Annual Report on Form 20-F
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock provides an update on 2022 revenue guidance
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.